Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.325 USD | +3.93% | +4.12% | +63.98% |
Evolution of the average Target Price on Actinium Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Actinium Pharmaceuticals, Inc.
Stephens Inc. | |
Maxim | |
B. Riley | |
HSBC | |
HC Wainwright | |
William Blair & Co. | |
Cantor Fitzgerald | |
Alliance Global Partners |
EPS Revisions
- Stock Market
- Equities
- ATNM Stock
- Consensus Actinium Pharmaceuticals, Inc.